The proteinase K market size is calculated at USD 5.23 billion in 2025 and is expected to reach around USD 10.93 billion by 2034, growing at a CAGR of 8.54% for the forecasted period.Ottawa, Oct. 07, ...

RIBOMIC, Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, has conducted a Phase 2 clinical trial of umedaptanib pegol (anti-FGF2 aptamer) in pediatric ...

TB is an infectious disease that primarily affects the lungs. Early and accurate diagnosis is crucial so that patient ...

ICMR has approved an indigenous kit for cost-effective and effective TB testing in the country. Developed by Telangana-based ...

This new approach empowers public sector laboratories to scale up testing without incurring heavy investment in new machinery ...

India's ICMR has validated two new indigenous TB diagnostic tools from Huwel Lifesciences. The Quantiplus MTB FAST kit offers ...

AI edits to the blueprints for known toxins can evade detection. Researchers are improving filters to catch these rare biosecurity threats.

Breakthrough results in first fluorescent sensors capable of detecting glycine dynamics inside living cells at single-cell ...

University of Utah chemists unveil “Golden Broccoli,” the first fluorescent sensors capable of detecting glycine dynamics ...

A Multi-Party Team represented by Carnegie Mellon University researchers and private industry partners has secured an award of up to $26.7 million from the Advanced Research Projects Agency for Health ...